Jennifer Jarrett - Insider Trading & Ownership

Location
C/O Medivation, Inc., 525 Market St., 36 Th Floor, San Francisco, CA
Summary
The estimated net worth of Jennifer Jarrett is at least $5.01M dollars as of June 10, 2025. Jennifer Jarrett is the Chief Operating Officer of Arcus Biosciences, Inc. and owns shares of Arcus Biosciences, Inc. (RCUS) stock worth about $3.2M. Jennifer Jarrett is the Director of Syndax Pharmaceuticals Inc and owns shares of Syndax Pharmaceuticals Inc (SNDX) stock worth about $1.8M. Jennifer Jarrett is the Former Director of Surrozen, Inc./DE and owns shares of Surrozen, Inc./DE (SRZN) stock worth about $11.4K.
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Jennifer Jarrett

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RCUS Arcus Biosciences, Inc. Chief Operating Officer $3.2M Jan 23, 2025
SNDX Syndax Pharmaceuticals Inc Director $1.8M Feb 5, 2025
SRZN, SRZNW Surrozen, Inc./DE Former Director $11.4K Aug 11, 2021
ARNA ARENA PHARMACEUTICALS INC Director Mar 11, 2022
RDUS Radius Health, Inc. Director Aug 15, 2022
SGMT Sagimet Biosciences Inc. Director Jun 9, 2025
ZURA Zura Bio Ltd Director May 21, 2025

Insider Transactions Reported by Jennifer Jarrett:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.